Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)
NCT01281761
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG:
cetuximab/irinotecan/simvastatin
Sponsor
Samsung Medical Center